(Nasdaq: BMRA), a developer and manufacturer of diagnostic test systems and CDMO services provider, today announced it has entered into a Master Services Agreement (MSA) with a confidential life ...

Today, the transition to recombinants is underway, as they are being approved and adopted in IVD assays around the globe. I witnessed firsthand the shortage of native starting materials and helped ...

MT Group, a specialty biospecimen contract research organization (CRO) supplying clinically annotated human biospecimens to ...

TIB MOLBIOL developed the test using its "rapid response" library, with 15,000 designs and 3,000 controls.

Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") today reported positive early pilot performance data for ViraxImmune™, its blood-based test in development for Long COVID, myalgic ...

Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that it developed a Research Use Only (RUO) molecular PCR test, via its ...

Genedrive plc (LSE:GDR) has received approximately £0. 76 million from HMRC through the UK’s research and development tax ...

Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...

CellCarta, a leading global CRO laboratory to the biopharmaceutical industry, today announced a Strategic Partnership with Sonic Healthcare USA, Inc. ("SHUAS" or "Sonic") to launch the first ...

Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") today reported positive early pilot performance data for ...

AnteoTech has expanded its life sciences footprint in Japan, appointing Tokyo Stock Exchange-listed Cosmo Bio Co. as ...

Fujirebio recently announced that the US Food and Drug Administration (FDA) has granted clearance for the company’s Lumipulse in-vitro diagnostic (IVD) test for the assessment of amyloid pathology in ...